Syrris to Host Technical Seminars in India for R&D Chemists
News May 10, 2010
Syrris, has announced that, due to significant interest in India for its range of automated batch reactor and flow chemistry products, it will be hosting two applications-focused seminars.
Taking place on Monday 10th May (Hyderabad) and Thursday 13th May (Ahmedabad), each seminar will include introductory discussions and workshops.
Syrris’ Global Head of Sales, Dr. Omar Jina, will introduce seminars on calorimetry, sonocrystallization and flow chemistry. He said: “This is an extremely exciting time for Syrris Ltd India. With sales increasing at a rapid pace, we wanted to provide users with the opportunity to actively participate in workshops and discussions, ensuring that they are fully aware of the capabilities of each system.”
Since incorporating its Indian subsidiary in 2009, Syrris has experienced outstanding levels of success within the Indian market. Syrris’ flow chemistry products include FRX, a modular flow chemistry system and Africa, a fully-automated microreactor flow system.
The batch reactor products include the Atlas automated synthesis system, which provides complete control over one, or parallel, reactions up to 5 litres in vials, flasks or jacketed reactors. With its ability to provide temperature control and accurate results, the Atlas Calorimetry System has been particularly successful.
Methane Hydrate Formation Studied Using Novel MicroreactorNews
Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.READ MORE
University of Huddersfield Honorary Award Goes to RSC’s First Woman PresidentNews
The first woman President of the Royal Society of Chemistry, Professor Lesley Yellowlees, will collect an honorary award from University of Huddersfield, which will be presented at the University’s November Award Ceremonies.READ MORE
Drug Discovery Alliance Formed to Help Increase Drug Development Success RateNews
Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.READ MORE